King-Jones Heidyinsider trades
In SEC Form 4 filings, King-Jones Heidy is listed as See Remarks of Spyre Therapeutics, Inc. (SYRE). In the last 90 days, King-Jones Heidy sold $5.11M of Spyre Therapeutics, Inc. (SYRE) on the open market and bought none. All 10 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | See Remarks | 16 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | M | 28,933 | $14.50 | $419,529 | 31,778 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 400 | $89.24 | Sale −$35,696 | 31,378 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 16,605 | $90.35 | Sale −$1,500,262 | 14,773 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 7,228 | $91.35 | Sale −$660,278 | 7,545 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 2,100 | $92.70 | Sale −$194,670 | 5,445 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 2,600 | $93.46 | Sale −$242,996 | 2,845 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | M · derivative | 28,933 | $14.50 | $419,529 | 482,478 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 2 | Sep 3 | M | 400 | $14.50 | $5,800 | 3,245 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 2 | Sep 3 | S | 400 | $90.00 | Sale −$36,000 | 2,845 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 2 | Sep 3 | M · derivative | 400 | $14.50 | $5,800 | 511,411 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | M | 27,999 | $14.50 | $405,986 | 30,844 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 4,845 | $86.40 | Sale −$418,608 | 25,999 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 16,548 | $87.20 | Sale −$1,442,986 | 9,451 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 6,206 | $88.17 | Sale −$547,183 | 3,245 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 400 | $89.38 | Sale −$35,752 | 2,845 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 27,999 | $14.50 | $405,986 | 511,811 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.